Completed
Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer
NCT04004221
- Conditions
- Locally Advanced or Metastatic Urothelial Bladder Cancer
- Locations
-
- Anhui Provincial Hospital Hefei, Anhui, China
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
- Peking University First Hospital Beijing, Beijing Municipality, China